Skip to main content

Table 1 Characteristics of the study population at baselines I and II

From: MIND diet and the risk of dementia: a population-based study

 

Baseline I (between 1989 and 1993) (N = 5375)

Baseline II (between 2009 and 2012) (N = 2861)

Sex (women)

3169 (59.0)

1643 (57.4)

Age (years)

67.7 ± 7.8

75.3 ± 5.9

Education attainment

 Primary

1102 (20.6)

192 (6.8)

 Lower

2281 (42.6)

1215 (43.3)

 Intermediate

1504 (28.1)

930 (33.1)

 Higher

463 (8.7)

469 (16.7)

Smoking status

 Never

1800 (33.7)

914 (32.0)

 Former

2296 (43.0)

1667 (58.4)

 Current

1247 (23.3)

274 (9.6)

Body mass index (kg/m2)

26.3 ± 3.6

27.4 ± 4.2

Physical activity (MET h/week)

83.4 ± 43.9

50.0 ± 45.4

Daily energy intake (kcal)

1974 ± 499

1994 ± 658

Diabetes (yes)

357 (6.9)

418 (15.2)

Hypercholesterolemia (yes)

3602 (67.1)

1549 (56.1)

Hypertension (yes)

3202 (59.8)

2461 (87.0)

Depressive symptoms (yes)

314 (18.7)

713 (15.7)

History of stroke (yes)

98 (1.8)

145 (5.1)

APOE ɛ4 carrier (yes)

1416 (27.5)

703 (26.1)

Diet scores, mean ± standard deviation (range)

 MIND diet

5.9 ± 1.3 (2.0–11.5)

7.4 ± 1.6 (1.5–13.5)

 Dutch dietary guidelines

6.8 ± 1.8 (1–13)

6.8 ± 1.8 (1–13)

 Mediterranean diet

36.7 ± 3.3 (20–47)

37.1 ± 4.1 (19–51)

  1. Data are shown for non-imputed data and are presented as mean ± standard deviation for continuous variables and number (percentages) for categorical variables unless stated otherwise
  2. Abbreviations: APOE Apolipoprotein E, MET Metabolic equivalent of task, MIND Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay; N, total number of participants